Seretide Disc standard
Recall
|
Medicines
|
22/02/2018
The marketing authorization holder has informed its supplied customers in a letter dated 22.02.2018 that it may not be possible to supply all doses. Therefore, the affected batch is recalled from the market as a precautionary measure.
Name of the medicinal product | Seretide Diskus standard 50 Mikrogramm/250 Mikrogramm - einzeldosiertes Pulver zur Inhalation |
---|---|
Marketing authorisation number(s) | 1-22901 |
Marketing authorisation holder | GlaxoSmithKline Pharma GmbH |
Batch number(s) | 5K8W |
Classification of the recall | 2 |
BASG reference number | INS-640.001-2460 |
Further inquiry note
Page last modified:
12/07/2022